Logo IAP

Member Login

Opportunities and Challenges for Research on Food and Nutrition Security and Agriculture in Europe | 05.12.17

National academies of science have a long tradition of engaging widely to strengthen the evidence base to underpin the delivery of enhanced food and nutrition security at regional and national levels. EASAC, the European...... read more

Homeopathic products and practices: assessing the evidence and ensuring consistency in regulating medical claims in the EU | 20.09.17

EASAC, the European Academies' Science Advisory Council, is publishing this Statement to build on recent work by its member academies to reinforce criticism of the health and scientific claims made for homeopathic products. The...... read more

Genome Editing: Scientific opportunities, public interests, and policy options in the EU | 23.03.17

A new report by the European Academies' Science Advisory Council on genome editing gives advice to European policy-makers on groundbreaking research involving genome editing and plants, animals, microbes and patients. In this...... read more

"Gain of Function" (in virology) | 16.10.15

Background of this latest EASAC study is the debate about risks and benefits of research that modifies viruses to better understand their functioning, in particular their potential to cause pandemics. Special attention is given...... read more

EASAC Summary on Personalised Medicine | 02.10.15

This document is a result of discussions in our Biosciences Steering Panel. EASAC will potentially take the issue of Personalised Medicine forward and produce a joint statement of our member academies. Download document here. ... read more

New Breeding Techniques | 13.07.15

In this statement we express our views on the critical importance of supporting innovation in plant breeding to contribute to EU objectives in agriculture and food and nutrition security. EASAC recommends that: - EU policy...... read more

Antimicrobial drug discovery: greater steps ahead | 01.10.14

Infectious diseases account for a substantial proportion of deaths worldwide. Continuing progress in the treatment of many infections is threatened by the growing resistance of pathogens to antimicrobial drugs. For example, in...... read more

Risks to plant Health: European Union Priorities for tackling emerging Plant Pests and Diseases | 10.03.14

EASAC Report 24 - Risks to Plant Health: EU Priorities for Tackling Emerging Plant Pests and Diseases The introduction and spread of pests and diseases among food crops and other plant species in forestry, horticulture and...... read more

Planting the future: opportunities and challenges for using crop genetic improvement technologies for sustainable agriculture | 27.06.13

EASAC policy report 21, June 2013 Agriculture faces major challenges to deliver food security at a time of increasing pressures from climate change, social and economic inequity and instability, and the continuing need to...... read more

Direct-to-consumer genetic testing for health-related purposes in the European Union: the view from EASAC and FEAM | 29.06.12

Until recently, human genetic testing was mainly confined to specialist medical genetic services, traditionally focusing on the relatively rare inherited disorders. However, the rapid pace of advance in DNA analysis has led to...... read more

Plant Genetic Resources for Food and Agriculture | 06.03.12

Agriculture in Europe faces some major challenges, associated with the need to deliver food security worldwide at a time of increasing pressures from population growth, climate change and economic instability and the continuing...... read more

Infectious diseases and the future: policies for Europe | 04.11.11

Summaries of the EASAC report: European Public Health and Innovation Policy for Infectious Disease: The View from EASAC These documents are summaries of the full EASAC report on Infectious Diseases. It offers readers...... read more

Impact of Engineered Nanomaterials on Health: Considerations for Benefit-Risk Assessment | 18.10.11

Nanotechnology and its importance for Europe Nanotechnology encompasses the design, characterisation, production and application of materials and systems by controlling shape and size at the nanoscale (nanometres). Nanomaterials...... read more

European public health and innovation policy for infectious disease: the view from EASAC | 07.04.11

There have been major advances during the past century in research into and treatment of infectious disease. However, assumptions that most infectious disease had been conquered are now seen to have been misplaced, and European...... read more

Synthetic Biology: An Introduction | 08.02.11

This document is a summary of the full EASAC report on Synthetic Biology. It offers readers a non-technical account of the principal content and conclusions of that report. The advent of synthetic biology, with its aim of...... read more

Realising European potential in synthetic biology: scientific opportunities and good governance | 02.12.10

Synthetic biology covers the design and construction of novel biological components, systems and processes "that are not already known to exist in nature" together with the re-design of existing biological systems....... read more

Climate change and infectious diseases in Europe | 30.03.10

Summary: Climate exerts both direct and indirect effects on the appearance and spread of human and animal infectious diseases. The impact of climate change on the transmission and geographical distribution of vector-borne...... read more

Healthcare-associated infections: the view from EASAC | 20.04.09

Healthcare-associated infections are an increasing problem for the European Union. Many Member States are spending a substantial proportion of their healthcare budget on these infections, which affect about 7% of patients in...... read more

Drug-resistant tuberculosis - full report | 24.03.09

Abstract: Worldwide, more than nine million people develop active tuberculosis (TB) every year, with 1.7 million dying from the disease. TB had been considered conquered in many European countries, but it has re-emerged as a...... read more

Drug resistant tuberculosis - summary | 24.03.09

Abstract: Worldwide, more than nine million people develop active tuberculosis (TB) every year, with 1.7 million dying from the disease. TB had been considered conquered in many European countries, but it has re-emerged as a...... read more

Combating the threat of zoonotic infections | 15.05.08

Abstract: Most new human pathogens reported in the past 25 years, such as influenza and SARS, have zoonotic origins. The risk of zoonotic infection, that is any infection transmissible between vertebrate animals and humans, is...... read more

The use of EU structural funds in science and technology | 14.02.08

Abstract: EASAC issued a statement reiterating the role of science and technology in developing the economies of the EU and that the Barcelona targets had been formal recognition of this.   To achieve these targets...... read more

Use of non-human primates | 31.01.08

Abstract: EASAC believes there is a need for carefully selected research questions to be answered with the use of non-human primates, but believes this should always be subject to a rigorous assessment of the welfare of the...... read more

Migration and infectious diseases | 18.09.07

Abstract: The healthcare screening and treatment processes for migrants entering the EU need to be better evaluated and coordinated across Member States   to prevent the potential spread of infectious diseases such as TB...... read more

Tackling antibacterial resistance in Europe | 21.06.07

Abstract: Deaths from previously treatable infections will become more common unless there is investment in the science needed to tackle antibiotic resistance the Royal Society has warned in a report published on 21 June...... read more

Vaccines: Innovation and Human Health | 09.05.06

Abstract: EASAC published on 9 May 2006 a report on vaccines: innovation and human health. The report focuses on the importance of vaccines: reviewing the latest scientific developments and their implications for public...... read more

Bureaucracy in the 6th Framework Programme | 22.02.06

Abstract: On 22 February 2006 the European Parliament held a workshop to examine the effect that the bureaucracy involved in applying for funding via Framework Programme 6. EASAC selected the speakers at the event and wrote up...... read more

Infectious diseases - importance of co-ordinated activity in Europe | 15.06.05

Abstract: EASAC published on 14 June 2005 a report on infectious diseases and the need for co-ordinated activity in Europe. In the report EASAC describes major challenges facing Europe from newly-emerging and long-standing...... read more

Genomics and crop plant science in Europe | 24.05.04

Abstract: EASAC published on 24 May 2004 a report on genomics and crop plant science in Europe. The report concludes that the successful application of new tools and methods in plant genetics to conventional farming is being...... read more

Towards 3%: attainment of the Barcelona target | 06.04.04

Abstract: EASAC published on 6 April 2004 a report of a workshop organised in the European Parliament at the request of the EP Industry Committee. The workshop was centred round EASAC case studies of the growth in R&D...... read more

Proposal for a Regulation on the addition of vitamins and minerals and of other substances to food | 19.02.04

Abstract: Review of COM 671 European Commission proposal for a regulation of the European Parliament and of the Council on the addition of vitamins and minerals and of certain other substances to food. Download... read more

Proposal for a Regulation on materials and articles intended to come into contact with food | 18.02.04

Abstract: Review of COM 689 European commission proposal for a regulation of the European Parliament and of the Council on materials and articles intended to come into contact with food. Download... read more

Review of RPA report "Inedibles in food product packaging" | 30.11.03

Abstract: This review has been prepared under the terms of a contract between EASAC and STOA, which provides for EASAC to undertake peer review of the scientific aspects of reports commissioned by STOA from external...... read more

Proposal for a Regulation on maximum residue levels of pesticides in plant and animal products | 20.11.03

Abstract: Briefing on the European Commission Proposal Regulation on maximum residue levels of and animal products [COM (2003) 117] Download... read more